HK1211952A1 - 重組蛋白 - Google Patents

重組蛋白

Info

Publication number
HK1211952A1
HK1211952A1 HK15112763.3A HK15112763A HK1211952A1 HK 1211952 A1 HK1211952 A1 HK 1211952A1 HK 15112763 A HK15112763 A HK 15112763A HK 1211952 A1 HK1211952 A1 HK 1211952A1
Authority
HK
Hong Kong
Prior art keywords
recombinant protein
recombinant
protein
Prior art date
Application number
HK15112763.3A
Other languages
English (en)
Inventor
彭文君
楊淑萍
彭宏智
陳郁鴻
Original Assignee
Ubi Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ubi Pharma Inc filed Critical Ubi Pharma Inc
Publication of HK1211952A1 publication Critical patent/HK1211952A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
HK15112763.3A 2012-12-18 2015-12-28 重組蛋白 HK1211952A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210551666.7A CN103864913A (zh) 2012-12-18 2012-12-18 重组蛋白
PCT/CN2013/089544 WO2014094579A1 (zh) 2012-12-18 2013-12-16 重组蛋白

Publications (1)

Publication Number Publication Date
HK1211952A1 true HK1211952A1 (zh) 2016-06-03

Family

ID=50903970

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112763.3A HK1211952A1 (zh) 2012-12-18 2015-12-28 重組蛋白

Country Status (16)

Country Link
US (1) US10428129B2 (zh)
EP (1) EP2937362B1 (zh)
JP (1) JP6083913B2 (zh)
KR (1) KR101796163B1 (zh)
CN (2) CN103864913A (zh)
AU (1) AU2013362474B2 (zh)
CA (1) CA2894913C (zh)
DK (1) DK2937362T3 (zh)
ES (1) ES2683983T3 (zh)
HK (1) HK1211952A1 (zh)
MY (1) MY178192A (zh)
NZ (1) NZ708796A (zh)
PL (1) PL2937362T3 (zh)
SG (1) SG11201504096RA (zh)
TW (1) TWI507415B (zh)
WO (1) WO2014094579A1 (zh)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850004274A (ko) 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US7217689B1 (en) 1989-10-13 2007-05-15 Amgen Inc. Glycosylation analogs of erythropoietin
SG88714A1 (en) 1989-11-06 2002-05-21 Cell Genesys Inc Production of proteins using homologous recombination
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
ZA946122B (en) 1993-08-17 1995-03-20 Amgen Inc Erythropoietin analogs
AU3357295A (en) 1994-08-31 1996-03-22 Prodevco (N.Z.) Limited Improvements in or relating to a composter
BR9905867A (pt) 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
KR101229995B1 (ko) 2000-12-11 2013-02-06 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
JP3946638B2 (ja) * 2000-12-11 2007-07-18 シージェイ コーポレーション 生体内エリスロポエチン活性が増強された融合蛋白質
US6987172B2 (en) * 2001-03-05 2006-01-17 Washington University In St. Louis Multifunctional single chain glycoprotein hormones comprising three or more β subunits
KR100467750B1 (ko) * 2001-11-29 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
US7553940B2 (en) 2006-02-03 2009-06-30 Modigene Inc Long-acting EPO polypeptides and derivatives thereof and methods thereof
CN101337988B (zh) * 2006-10-31 2013-01-09 沈阳三生制药有限责任公司 一种新的***类似物
CN101678079B (zh) * 2006-11-28 2013-12-25 韩诺生物制约株式会社 修饰的***多肽及其治疗用途

Also Published As

Publication number Publication date
CN103864913A (zh) 2014-06-18
AU2013362474B2 (en) 2016-09-22
PL2937362T3 (pl) 2018-09-28
MY178192A (en) 2020-10-06
NZ708796A (en) 2016-08-26
CN105102483B (zh) 2019-03-01
EP2937362A4 (en) 2016-05-18
CA2894913A1 (en) 2014-06-26
KR101796163B1 (ko) 2017-11-10
JP2016501897A (ja) 2016-01-21
TWI507415B (zh) 2015-11-11
ES2683983T3 (es) 2018-10-01
DK2937362T3 (en) 2018-07-16
SG11201504096RA (en) 2015-07-30
TW201434856A (zh) 2014-09-16
WO2014094579A1 (zh) 2014-06-26
KR20150085839A (ko) 2015-07-24
CA2894913C (en) 2019-05-07
EP2937362B1 (en) 2018-05-16
EP2937362A1 (en) 2015-10-28
CN105102483A (zh) 2015-11-25
US20160176940A1 (en) 2016-06-23
JP6083913B2 (ja) 2017-02-22
US10428129B2 (en) 2019-10-01
AU2013362474A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
HRP20190454T1 (hr) Rekombinantni faktor viii proteini
EP2929045A4 (en) PROTEIN EXPRESSION REINFORCING POLYPEPTIDES
EP2857033A4 (en) SKIN-PUNKING PEPTIDE
EP2812347A4 (en) AUTOPHAGIA-INDUCING PEPTIDE
HK1205524A1 (zh) 改造的構象穩定蛋白質
GB201217524D0 (en) Recombinant organisms
HK1209138A1 (en) Peptides
HK1204948A1 (zh) 放射線滅菌耐性的蛋白組合物
SG11201404180RA (en) Cho-gmt recombinant protein expression
EP2865686A4 (en) EGFR-BINDING PEPTIDE
GB201204868D0 (en) Peptides
GB201200555D0 (en) Peptide
EP3560952C0 (en) VARIANT OF BPIFB4 PROTEIN
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201304973D0 (en) Recombinant protein
GB201223114D0 (en) Novel peptide
HK1201752A1 (zh) 鏈格孢屬的肽
GB201213672D0 (en) Protein
EP2891663A4 (en) PEPTIDE DERIVED FROM PSF1
HK1211952A1 (zh) 重組蛋白
GB201210286D0 (en) Recombinant polypeptide
GB201215901D0 (en) Protein modification
GB201200743D0 (en) Protein bridges
GB201221414D0 (en) Trans-locating peptide
GB201220328D0 (en) Peptides